Iambic Therapeutics (fka Entos)

Freeflow Ventures is hosting a discussion that will focus on portfolio company Entos on Wednesday August 31st at 8am Pacific / 11am Eastern. You can register here and invite others that might be interested.

Entos combines machine learning and automated chemistry to revolutionize small-molecule therapeutics design. Their customers are researchers and leaders in healthcare developing therapies and cures for diseases like cancer. Entos was recently named to Forbes Magazine’s 2022 list of groundbreaking artificial intelligence companies. Learn more about the company at here.

The discussion will kick off with a presentation and introductory remarks from the cofounders, Tom Miller and Fred Manby. It will be followed by a deep dive discussion into the technology and its use cases in human health.